COMPOSITION FOR PROTEASOME INHIBITION

摘要

Compositions comprising one or more practically insoluble proteasome
inhibitors and a cyclodextrin, particularly a substituted cyclodextrin,
substantially increase the solubility of these proteasome inhibitors and
facilitate their administration. Such compositions optionally comprise a
buffer. Methods of treatment using such compositions are also disclosed